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Summary 
Mice transgenic for the hemopoietic growth factor, granulocyte-macrophage colony-stimulating 
factor (GM-CSF), exhibit a sustained elevation of GM-CSF levels and a 50-100-fold elevation 
of peritoneal macrophage cell numbers. The excess cell numbers were found to be generated 
in pre-adult life, with numbers remaining relatively constant thereafter.  In the pre-adult period, 
no abnormalities were noted in the number or composition of blood, bone marrow, or spleen 
cells, the type or number of GM progenitor cells in the marrow or spleen, or the rate of appearance 
of newly formed monocytes in the peripheral blood. Peritoneal macrophages in pre-adult transgenic 
mice exhibited elevated mitotic activity and, after  tritiated thymidine labeling,  a more rapid 
accumulation of labeled progeny. The increase in peritoneal macrophage cell numbers appears, 
therefore, to be based on a GM-CSF-induced increase in local proliferative activity by peritoneal 
macrophages. This increased activity declined at the age of 8-10 wk, in parallel with a change 
in the morphology of the transgenic macrophages and an increase in binucleate and multinucleate 
macrophages arising by cell fusion. This change in macrophage phenotype was restricted to the 
transgenic mice and may therefore be a consequence of continued overstimulation by GM-CSF. 
T 
issue macrophages are usually regarded as having origi- 
nated from blood monocytes that have seeded in the 
tissues, then altered their morphology and function according 
to their location (1). Most blood monocytes are generated 
by GM progenitor cells located in the bone marrow (2). The 
concept that tissue macrophages are derived from blood mono- 
cytes of marrow origin has been validated by an analysis of 
the process by which macrophages accumulate in induced peri- 
toneal exudates (3, 4). However, the origin of resident mac- 
rophages in the peritoneal cavity of adult animals has been 
a more contentious issue. Kinetic analyses of resident perito- 
neal macrophage populations in adult parabiotic rodents have 
given discordant data, indicating that this population may 
be either partly (5) or wholly (6) self-sustaining by local mi- 
totic activity. 
The CSFs have been identified as the major regulators of 
granulocyte and macrophage formation in vivo (2). The in- 
taperitoneal injection into mice of GM-CSF elicited a major 
rise in peritoneal macrophage numbers (7). However, only 
minimal changes occurred in progenitor cell levels in the 
marrow or spleen, and only a barely detectable rise in blood 
monocytes was seen. In view of the increased proliferative 
activity of peritoneal macrophages in these mice, the observed 
rise in cell numbers was likely to be due to an action of GM- 
CSF in stimulating local macrophage mitotic activity. Com- 
peUing evidence in support of the local origin of increased 
peritoneal macrophage numbers after CSF stimulation has 
recently been produced by studies on the administration of 
macrophage (M)-CSF to osteopetrotic mice (8). 
Adult GM-CSF transgenic mice with constitutively elevated 
levels of GM-CSF in the serum and peritoneal cavity (9) ex- 
hibit, in exaggerated  form, the pattern of response elicited 
in normal mice by the injection of GM-CSE Adult trans- 
genic mice were observed to have grossly elevated levels of 
peritoneal and pleural macrophages, yet marrow and spleen 
populations were near normal in numbers and composition, 
as were the levels of GM progenitor cells (10). 
The present observations have established the time course 
of development of the elevated numbers of peritoneal macro- 
phages in GM-CSF transgenic mice and have analyzed  the 
possible origin of these excess cells during pre-adult life. The 
data suggest that the excess macrophages arise predominantly 
by enhanced local cell division in the peritoneal cavity. 
Materials and Methods 
Mice.  Mice  used were male and female members of the GM- 
CSF transgenic line in which insertion of the transgene is on an 
autosomal chromosome. The derivation of this line has been de- 
scribed elsewhere (10). The founder was a (C57BL  x  SJL)F1 
mouse and the line was maintained by crossing male transgenic 
mice with normal (C57BL ￿  SJL)F1 females. Approximately  half 
the progeny of such matings were transgenic  and these were readily 
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phage invasion  and consequent damage to ocular tissue. The normal 
littermate mice were used as control mice in each experiment. 
Observations.  Transgenic and control littermate mice were ex- 
amined between the ages of 7 and 170 d. Mice were anesthetized 
and white cell, hematocrit, platelet levels, and erythrocyte sedimen- 
tation  rates (ESR)  1 were determined  from  retroorbital  plexus 
blood. The mice were then reanesthetized and exsanguinated from 
the axillary vessels. The serum was separated, diluted 1:4 in 5% 
FCS (Hyclone  Laboratories,  Logan, UT) in 0.9% saline,  then passed 
through millipore filters (MiUipore Corp., Bedford,  MA). A volume 
of 2 ml of 5% FCS/saline was injected into the peritoneal cavity 
and, after gentle massage, the fluid was reharvested using a soft 
plastic pipette. Spleens were weighed, then prepared as dispersed 
cell suspensions. Femur marrow cells were collected and prepared 
as dispersed cell suspensions in 2 ml of 5% FCSAaline. Cytocen- 
trifuge preparations  of  peritoneal, spleen, and macrophage  cells were 
stained with May-Grfinwald  Giemsa (BDH Chemicals, Kilsyth, 
Australia), coded, then typed at magnifications of 600. 
Culture Assays.  Progenitor cell levels in the marrow, spleen, 
and peritoneal populations were determined from the culture of 
25,000 cells from each source in 1-ml agar medium cultures (final 
concentrations  of 20% FCS and 0.3% agar) containing either 1,000 
U of r murine GM-CSF (sp act 10  s U/rag), or 0.1 ml of PWM- 
stimulated spleen  conditioned  medium (SCM), the latter containing 
400 U each of GM-CSF and multi-CSF (2). After 7 d of incuba- 
tion at 37~  in a fully humidified atmosphere of 10% CO2 in air, 
colonies were counted in quadruplicate cultures, the cultures were 
then fixed by adding 1 ml of 2.5% glutaraldehyde. After 4 h, the 
cultures were floated intact onto glass slides, dried, and stained for 
acetylcholinesterase. These slides were then stained with Luxol- 
Fast-Blue and hematoxylin (BDH Chemicals). Differential colony 
counts were performed on coded slides at magnifications  of  400 (2). 
Levels of GM-CSF in transgenic and littermate sera were deter- 
mined using serial twofold dilutions of each serum in microwell 
assay  cultures containing 200 FDC-P1 cells (9). After 48 h of  incu- 
bation, cell counts were performed using an inverted microscope. 
Observed GM-CSF levels  were transformed to bone marrow U/ml 
by calculation from the results obtained in each assay using the 
half-maximal points from titrations of a standard preparation of 
r murine GM-CSF of known activity (100 U/ml). 
Autoradiographic Analysis of GM-CSF Receptors.  Purified  r non- 
glycosylated  murine GM-CSF was labeled with 12sI, as previously 
described (11). Binding to washed peritoneal cells from 10-wk-old 
GM-CSF transgenic or littermate control mice and subsequent au- 
toradiographic analysis of the labeled cells were performed as de- 
scribed previously (12). 
Tritiated Thymidine Studies.  4- and 8-wk-old transgenic and lit- 
termate mice were injected intravenously with 5 #Ci/g tritiated 
thymidine (Amersham, Bucks, UK) in an injected volume of 0.2 
ml. At intervals from 1 h to 4 d after injection, replicate smears 
or cytocentrifuge preparations were prepared of  blood, peritoneal, 
or marrow cells from four separate mice on gelatin-coated slides. 
After fixation  in methanol, these were dipped  in Kodak  NTB2 emul- 
sion (Eastman Kodak, Rochester, NY) and exposed for up to 37 d. 
After  development, the  preparations were stained with  May- 
Gr/inwald Giemsa, and cell labeling examined at magnifications 
of 600. 
StatisticalAnalysis.  Data were analyzed  for statistically  significant 
differences using the Student's t test. 
1 Abbreviations used in this paper: ESR, erythrocyte  sedimentation rate; 
SCM, spleen-conditioned  medium. 
Results 
Serum GM-CSF Levels.  The transgenic state of all mice 
used in the study was verified by assays of GM-CSF levels 
in the serum. GM-CSF levels were elevated in all the trans- 
genie mice,  but at 2-3 wk of age,  the degree of elevation 
(640  _+  380  U/m1) was slightly lower than in adult mice 
(1,080  •  710  U/ml).  No  GM-CSF  was  detected in  the 
majority of littermate sera (lower detection limit 20 U/ml), 
and mixing experiments showed that littermate serum did 
not block the ability of the assay to detect known amounts 
of added GM-CSF in the concentration range of 100-1,000 
U/ml. 
Peritoneal  Cell Populations in Transgenic  Versus Control Mice. 
Peritoneal macrophage numbers though variable, were elevated 
in all transgenic mice compared with littermate control mice 
of comparable age (Fig.  1).  In some transgenic mice,  cell 
numbers were up to 1,000-fold higher than in control mice, 
but in most mice the elevation was -o50-fold. Peritoneal mac- 
rophage numbers were maximal in transgenic mice at 8-10 
wk of age, after which the numbers declined slightly with 
increasing age.  As can be seen in Fig.  1,  the characteristic 
excess of peritoneal macrophages in adult transgenic mice was 
achieved by a progressive  logarithmic rise during the first 4 
wk of life. Analysis of mice aged between 2 and 4 wk indi- 
cated that the doubling time of the macrophage population 
was 5.4 d in transgenic mice versus 7.8 d in control mice. 
A characteristic feature of the peritoneal macrophage popu- 
lations from transgenic mice was the progressive development 
with age of changes in the morphology of the cells. In mice 
aged <4-wk-old, the nucleus was of variable morphology and 
was surrounded by only a small rim of cytoplasm. In con- 
trast, in adult mice the transgenic macrophages were enlarged 
in size, predominantly had a round nucleus, and exhibited 
a bulky cytoplasm (Fig. 2). Another distinctive feature of trans- 
genie macrophages was an age-related  rise in the frequency 
of binucleate  and  multinucleate  cells.  The  frequency of 
binudeate macrophages commenced rising after 3 wk of age, 
and in most adult mice comprised 2-20% of the macrophages. 
The development of multinucleate macrophages with up to 
eight nuclei per well was slower,  and these cells were not 
observed in transgenic mice <8 wk of age.  In many trans- 
genic mice, 5-10% ofmacrophages were multinucleate. GM- 
CSF transgenic mice of this line begin dying with a wasting 
disease and paresis from the age of 8 wk. However, the de- 
velopment of binucleate and multinucleate cells was not de- 
pendent on the development of clinical  illness,  since levels 
of both types of cell were similar in apparently healthy and 
moribund mice. 
Blood, Marrow, and Spleen Cellularity.  To determine if the 
increased numbers of peritoneal macrophages in transgcnic 
mice  were  derived  from  extraperitoneal  sources  (blood, 
marrow,  or  spleen),  an  analysis  was  made  of these  ex- 
traperitoneal populations in the 2-8 wk age period during 
which the distinctive pattern seen in adult transgenic mice 
was established. 
No differences in blood white cell levels, and particularly 
in monocyte levels, were observed  between transgenic and 
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Figure 1.  Change  with age in the total number of 
macrophages in the peritoneal  cavity  of  GM-CSF trans- 
genic mice and littermate control mice. Each point 
represents data from an individual mouse. 
control mice in the age range of 4-14 wk (Table 1). Hemato- 
crit levels also were not significantly different except for low 
values in two 8-wk-old transgenic  mice which showed bleeding 
in the peritoneal cavity, a feature of the disease state developing 
Figure 2.  Morphology  of peritoneal macrophages in GM-CSF trans- 
genic mice aged (A) 2 wk and (B) 10 wk. Note the mitotic activity in 
the younger  macrophages, the rounded nuclei of  the macrophages  in older 
mice, and the presence of binucleate and multinucleate cells. 
with increasing age in this transgenic line.  Platelet levels in 
transgenic mice were slightly lower than in control mice, a 
trend confirmed in a more extended series  of observations 
of apparently  normal  14-wk-old transgenic  mice. 
In mice aged between 2- and 8-wk-old, there were no con- 
sistent differences between transgenic and control mice in total 
femur cell counts  (Table 2),  or in  the composition  of the 
marrow population.  In this age range,  the spleen in trans- 
genic mice was slightly larger in weight than that in control 
mice, but again no major differences were observed in the 
size (Table 2) or cellular composition of the spleen between 
the  two types of mice.  As both  types of mice progressed 
through this age range,  the spleen switched from an erythroid 
to a mainly lymphoid  tissue. 
Progenitor Cell Levels in  Transgenic Versus Littermate  Mice. 
The frequency of GM progenitor (colony-forming) cells was 
determined  in  marrow,  spleen,  and  peritoneal  cavity cells 
during  the  period  in  which  peritoneal  cell numbers  were 
diverging in transgenic and littermate control mice. As shown 
in Table 2, levels of progenitors were in fact marginally higher 
in the marrow and spleen of littermate mice in the 2-8-wk- 
old age range  than  in  transgenic  mice,  but in  no instance 
were these differences statistically  significant. 
Of special interest was the possibility that  the transgenic 
peritoneal populations might contain large numbers of pro- 
genitor cells.  In fact, few were detected and their frequency 
was lower in transgenic than in control mice (Table 2). Fur- 
thermore,  the majority of the progenitor cells in the perito- 
neal cavity were committed to the granulocyte lineage,  and 
would not have generated macrophage progeny. Mixing ex- 
periments using transgenic or littermate peritoneal cells with 
bone marrow cells from either source demonstrated no ability 
of peritoneal  cells,  in  the concentrations  cultured,  to  sup- 
press colony formation by progenitor cells in marrow popu- 
lations  (data not  shown). 
879  Metcalf  et al. Table  1.  Blood Cell Counts in  Transgenic vs.  Control Mice 
Total cells//~l 
Type  Age  Neutrophils  Lymphocytes  Monocytes  Eosinophils  Platelets  Hematocrit  ESR* 
GM-CSF 
Transgenic 
Littermate 
wk 
4  600  _+  250*  3,750  _+  1,620  240  +  170 
8  510  _+  360  2,530  _+  1,700  240  _+  130 
14  880  _+  890  7,320  +  2,800  360  _+  420 
4  580  +  320  4,960  _+  1,090  440  _+  210 
8  280  _+  90  4,390  _+  1,610  190  _+  80 
14  670  +  720  6,880  _+  2,300  360  -+  260 
x I0-6//~I  mm/h 
40  +_  50  0.84  _+  0.21  44  +  2  3.5  _+  1.4 
30  -+  20  0.78  +  0.14  46  +  2  6.3  _+  2.0 
70  +  80  0.74  +_ 0.14  46  +_  3  1.7  _+  1.5 
30  _+  50  0.91  _+  0.12  45  +  1  3.1  _+  1.2 
70  +  70  1.06  _+  0.18  48  +  1  1.6  _+  0.7 
90  +_  100  0.93  +  0.14  48  +  1  1.6  +  0.7 
Six to eleven mice examined per group. 
* Mean values +_ SD. 
* ESR., erythrocyte sedimentation rate. 
The colonies developing in cultures of transgenic cells were 
identical in size range to those grown from control cells,  and 
in no instance did autonomous colonies develop in unstimu- 
lated cultures. Attention was paid to the development of mac- 
rophage dusters  in stimulated  or unstimulated  cultures  of 
transgenic cells, in particular peritoneal cells. However, at the 
cell concentrations cultured, in few instances did clusters de- 
velop in cultures of peritoneal cells,  and where present, these 
were more numerous in control cultures.  A  similar lack of 
difference in cluster frequency was noted in cultures of marrow 
or spleen cells. 
Morphological typing of the colonies developing in trans- 
genic cultures indicated no unusual relative frequency of gran- 
ulocyte, granulocyte macrophage, macrophage, or eosinophil 
colonies compared with cultures  of cells from control mice 
of the same age. 
Local Peritoneal Macrophage Mitotic Activity.  The failure to 
find any significant differences between the blood, marrow, 
or spleen populations between transgenic and control mice 
directed attention to possible differences in the local behavior 
of peritoneal macrophages as the basis for the observed differ- 
ences in cellularity. 
No mitotic activity was observed in the lymphocytes, eo- 
sinophils,  neutrophils,  or mast cells in the peritoneal cavity 
of either transgenic or control mice. However, mitotic figures 
were clearly evident in peritoneal macrophages from 2-4-wk- 
old mice.  In 24 mice of each type, aged 2-4  wk,  the fre- 
quency  of mitosis  per  103  macrophages  was  significantly 
Table  2.  GM Progenitor Cell Frequency in the Marrow and Spleen of Transgenic vs. Littermate Mice 
Progenitor cells/2.5  x  104 cells 
No.  of  Total marrow  Spleen 
Type  Age  mice  cells  weight  Marrow  Spleen  Peritoneal  cavity 
GM-CSF 
Transgenic 
Littermate 
wk  ￿  -6  mg 
2  7  14.2  _+  5.9  68  _+  17  29  _+  9  12  _+  5  0 
3  9  19.3  _+  5.1  91  _+  50  43  _+  15  11  _+  10  0.8  +  1.4 
4  8  23.5  _+  4.5  128  +  37  46  +  12  12  _+  7  0.1  +  0.2 
8  6  35.4  _+  3.2  159  +  23  46  _+  9  2  _+  2  0.4  _+  0.5 
2  7  15.3  _+  4.8  49  _+  4  38  +-  13  17  _+  7  0.9  _+  0.9 
3  9  20.8  _+  8.2  64  _+  13  50  -+  7  13  +_  5  0.9  +_  1.1 
4  8  27.5  _+  6.4  91  _+  25  50  _+  13  9  +  8  0.3  _+  0.4 
8  6  35.6  _+  5.2  95  _+  31  59  +  10  6  _+  6  0.2  _+  0.3 
Marrow cell counts represent total cells from one femur per mouse. Mean values +  SD. All cultures contained 25,000 cells and were stimulated 
by 0.1 ml PWM-stimulated spleen conditioned medium. 
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Figure 3.  Frequency of mitoses 
per thousand  peritoneal  macro- 
phages in transgenic  (0) and lit- 
termate control mice (0). Mean 
values  +_  SD of groups  of 8-10 
mice at each age. 
higher in transgenic mice (7.1  _+  4.7) than in control mice 
(4.0  +-  3.4) (t  =  2.95, p < 0.01). As shown in Fig. 3, the 
frequency of mitoses fell in mice of  both types with increasing 
age, but at each time point the frequency was higher in trans- 
genic than in control mice. 
The likely differences in peritoneal macrophage prolifera- 
tive activity were examined in more detail by autoradiography 
of cells from mice injected with tritiated thymidine. A se- 
quential analysis was made of mice of two ages: (a) 4 wk 
of age, when an active increase was occurring in peritoneal 
macrophage numbers, and (b) 8 wk of age, when total peri- 
toneal cell numbers had achieved their maximum levels. 
As shown in Fig. 4, in 4-wk-old mice, the percentage of 
macrophages  in S phase and labeled at 1 h after thymidine 
injection in transgenic  mice (9  _+  2%) was almost double 
the percentage in littermate mice (5  _+  0.5%). After initial 
labeling,  the percentage  of labeled cells rose progressively 
during the next 72 h, reaching 45 _+ 5% in transgenic mice, 
but only 18  _+  2% in littermate mice. At 72 h, levels of la- 
beled cells appeared to be approaching  a plateau in mice of 
both types. The number of available animals did not permit 
a more complete analysis of the mitotic cell cycle, but the 
fall in mean grain counts with time indicated that cell cycle 
times of labeled cells were <24 h, much shorter than the ob- 
served doubling times for the populations. This indicates that 
two subsets of cells were probably present in the peritoneal 
macrophage population  -  a smaller mitotically active subset 
and a larger, quiescent population. The data suggested that 
the major difference between the two types of mice was the 
higher proportion of transgenic macrophages in the mitoti- 
cally active pool.  It was evident from the grain counts of 
labeled cells at 48 and 72 h that many intensely labeled cells 
were present in mice of both types at these late time points, 
indicating that some progeny of the cells that had been in 
S phase at the time of initial labeling had not undergone fur- 
ther cell divisions, but had left the mitotic pool. This would 
account for the failure of the percentage of labeled cells to 
rise uniformly with time, since an increasing number of la- 
beled cells were no longer exhibiting mitotic activity. 
The labeling pattern in 8-wk-old mice was sharply different 
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Figure 4.  Frequency of labeled macrophages  in transgenic  and litter- 
mate control mice at intervals after pulse labeling by the intravenous injec- 
tion of tritiated thymidine.  Mean values  +  SD of four separate mice at 
each time point. 
from that in 4-wk-old mice. Whereas the percentage of la- 
beled macrophages was again higher in transgenic  than in 
littermate mice, only 2  __  1%  of transgenic  macrophages 
were in S phase at the time of labeling,  and by 72 h only 
16  __  4% of cells were labeled, a rate of increase in percent 
labeled cells not significantly different from that observed in 
littermate control mice. 
These data suggest that a marked reduction had occurred 
in the relative size of the active pool of macrophages by the 
age of 8 wk, with little difference in the behavior  of this 
population between the two types of mice at a time when 
total cells numbers were being maintained at a stable level. 
One possible basis for the decline in mitotic activity of 
adult transgenic macrophages might have  been the failure of 
these cells to continue to express membrane receptors for GM- 
CSE However, as shown in Fig. 5, an autoradiographic anal- 
),sis of macrophages from 10-wk-old transgenic  mice after 
labeling  in vitro with 12SI-GM-CSF showed not only the 
continuing presence  of  receptors on all transgenic macrophages, 
but also that receptor numbers were higher (grain counts per 
cell) than on macrophages from the peritoneal cavity of lit- 
termate control mice of the same age. 
Analysis of the tritiated  thymidine labeling  pattern of 
binucleate  and muhinucleate transgenic macrophages indi- 
cated, as has been shown in other systems  where multinucleate 
macrophages develop (13, 14), that these cells arose by fusion 
rather than by endomitosis. The cell shown in Fig. 6 can have 2O 
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to that in control mice. Since blood monocyte levels were 
similar in both types of mouse, these data exclude the possi- 
bility that monocytes were transiting from the marrow to 
the blood of transgenic mice more rapidly than in control 
mice or that, in transgenic mice, greatly increased numbers 
of monocytes could have entered the peritoneal cavity from 
the blood.  Furthermore, at  1 h  after the administration of 
tritiated thymidine, when some peritoneal cells were labeled, 
blood monocytes were unlabeled. At 24 h, the labeled peri- 
toneal macrophages did  not resemble the morphology of 
monocytes, again indicating that the transgenic mice were 
not exhibiting a massive acceleration of entry of labeled cells 
from the blood into  the peritoneal cavity. 
Figure 5.  Autoradiographic analysis of the binding of 12SI-GM-CSF to 
peritoneal macrophages  from GM-CSF transgenic and littermate control 
mice aged 10 wk. Grains/cell reflects the frequency of GM-CSF receptors 
on individual cells. 
arisen only by fusion of an unlabeled cell with at least two 
other labeled cells. This conclusion is supported by the failure 
to find labeling of any nucleus in binucleate or multinucleate 
cells  1 h  after labeling,  indicating that none of these cells 
were in S phase.  Furthermore, an analysis of binucleate cells 
from mice 72 h after labeling showed a combination of a la- 
beled and an unlabeled nudeus in 15 of 177 binucleate cells, 
and labeling of  both nuclei in 2 of 177 cells. In 50 multinucleate 
cells, labeling of one or two nuclei was observed in nine of 
the cells. The frequency of  labeled binucleate and multinucleate 
cells was lower at 72 h than that of transgenic macrophages 
with a single nucleus. Nevertheless, the data suggested that 
cell fusion did not involve exclusively aged cells as the pres- 
ence of a labeled nucleus in such cells indicated, at least for 
these cells, that one of the fusion partners recently had been 
in active cell cycle. 
The accumulation with time of labeled monocytes in the 
bone marrow and blood of transgenic animals was similar 
Figure 6.  A single multinucleate macrophage from a GM-CSF trans- 
genic mouse 72 h after labeling with tritiated thymidine. The presence 
of two nuclei with differing labeling intensities indicates that the cell arose 
by fusion. 
Discussion 
The present observations on GM-CSF transgenic mice have 
sought  to  establish  the  origin  of the  massively increased 
numbers of  peritoneal and pleural macrophages in adult mice 
of this type. The data indicated that, in adult mice, perito- 
neal macrophage numbers are relatively constant and, rather 
than increasing with age, actually decrease slightly. The ab- 
normally high levels of macrophages in transgenic mice were 
achieved in the first 8 wk of life, indicating that the cellular 
basis for the difference needs to be established by studies on 
mice in the pre-adult period. 
In principle,  the massively increased numbers of perito- 
neal macrophages in transgenic mice either could have come 
from an increased production of monocytes in the marrow 
and spleen with a subsequent increased delivery of mono- 
cytes via the blood to the peritoneal cavity, or could have 
arisen from increased local macrophage proliferative activity 
in the peritoneal cavity itself. 
The pre-adult period was characterized as a time when cir- 
culating GM-CSF levels were already markedly elevated.  No 
abnormalities were detected during the pre-adult period in 
bone marrow or spleen cell numbers, levels, or types of pro- 
genitor cells in these tissues, blood monocyte levels, or rates 
of appearance of newly-formed monocytes in the peripheral 
blood. The rise in peritoneal cellularity therefore appears  to 
be achieved without any detectable perturbation of  cell popu- 
lations generating monocytes that might have migrated into 
the cavity. In vitro analysis of the peritoneal populations failed 
to reveal an elevated frequency of  progenitor (colony-forming) 
cells in the local population but, because of the differing total 
cell numbers, the total number of progenitor cells was in- 
creased, possibly 20-50-fold.  As most of these progenitors 
were committed to the granulocyte lineage, they would not 
have contributed to local macrophage production. However, 
some increase in absolute numbers of macrophage progen- 
itors can be concluded to have been present and to have con- 
tributed to the observed increase in local macrophage prolifer- 
ative activity, although most of the dividing cells were likely 
to  have been more mature cells. 
GM-CSF appears to be a free exchange between the serum 
and the peritoneal cavity with GM-CSF concentrations being 
similar in both locations (9).  The situation documented in 
transgenic mice therefore mimics, in exaggerated form, the 
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in which little change is observed in blood, marrow, or spleen 
populations in contrast to the marked rise in the number and 
local mitotic activity of peritoneal macrophages (7). 
The peritoneal macrophages in pre-adult transgenic mice 
exhibited elevated mitotic activity sufficient to account for 
the shortened doubling time of the population observed during 
this period, given the likely cell cycle times for dividing mu- 
fine macrophages of 12-20 h, (15,  16). The labeling studies 
using tritiated thymidine indicated that not all transgenic peri- 
toneal cells were in active cell cycle. Instead, the mitotic ac- 
tivity was restricted to a subset of these cells and many of 
the progeny subsequently entered a non-cycling pool. The 
major difference between the transgenic and control mice was 
the larger size of the cycling subset in transgenic mice. In 
young transgenic mice, possibly more than 20% of the mac- 
rophages were in the cycling pool, versus about 10% in the 
control mice. The observations made were not able to estab- 
lish whether the length of the cell cycle in these dividing 
macrophages also differed between transgenic and normal mice 
and whether some noncycling transgenic macrophages were 
able to reenter the dividing pool. 
The origin, therefore, of the grossly increased peritoneal, 
and presumably pleural, populations of macrophages in GM- 
CSF transgenic mice appears to be a GM-CSF-induced in- 
crease in the proportion of the population able to exhibit 
proliferation-a  response similar to that observed after the 
local injection of GM-CSF in normal mice (7). A dramatic 
example of the ability of local CSF to induce major rises in 
the local peritoneal macrophage populations without inducing 
comparable changes in marrow, spleen, or blood monocytes 
populations, has been documented recently by studies on the 
responses of osteopetrotic (op/op) mice to the administra- 
tion of M-CSF  (8). 
Since GM-CSF levels remain grossly elevated in the trans- 
genic mice throughout life, it is interesting that peritoneal 
cell numbers did not rise progressively beyond 8-10 wk of 
life.  For some reason,  the nature of the peritoneal macro- 
phage population changes qualitatively after 8-10-wk-old in 
GM-CSF transgenic mice. After this time, the morphology 
of the cells is radically altered from that in younger mice as 
shown in Fig.  2, and there is a progressive increase in the 
proportion of binucleate and multinucleate cells. Since these 
changes were not seen in normal mice and the peritoneal mac- 
rophages in normal adult mice remain responsive to prolifer- 
ative stimulation by injected GM-CSF (7), the changes must 
be presumed to be long-term consequences of overstimula- 
tion by GM-CSF. The macrophages in older transgenic mice 
do, however, continue to express receptors for GM-CSF and 
to exhibit heightened functional activity as assessed by su- 
peroxide and I1,-1 production (17, 9), but they are no longer 
capable of exhibiting increased mitotic activity. 
Does this suggest that, after sustained proliferative stimu- 
lation by CSFs, a responding population eventually becomes 
refractory to further proliferative stimulation? This seems un- 
likely since patients with cyclic neutropenia have remained 
responsive to stimulation by injected G-CSF for several years 
(18).  This  suggests,  therefore, that peritoneal macrophage 
populations, as quasi-end-cells, exhibit an atypical response 
to continued proliferative stimulation, at least by GM-CSF, 
and are induced to alter their morphology and to remain 
capable of exhibiting heightened functional responses, but 
not increased cell division. That these changes are peculiar 
to cells in the peritoneal and pleural cavities is indicated by 
the failure to  observe multinucleate cell formation in the 
marrow or spleen populations. 
These observations have raised some unanswered questions 
regarding the nature of long-term responses to CSF stimula- 
tion, and the study has provided strong evidence that resi- 
dent peritoneal macrophages in GM-CSF transgenic mice be- 
have as an essentially independent cell population, expanding 
abnormally, then maintaining itself largely by local cellular 
proliferation. 
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